Assessment tool for pharmacy drug-drug interaction software
- PMID: 21555296
- DOI: 10.1331/JAPhA.2011.10054
Assessment tool for pharmacy drug-drug interaction software
Abstract
Objectives: To assess the performance of pharmacy clinical decision support (CDS) systems for drug-drug interaction (DDI) detection and to identify approaches for improving the ability to recognize important DDIs.
Practice description: Pharmacists rely on CDS systems to assist in the identification of DDIs, and research suggests that these systems perform suboptimally. The software evaluation tool described here may be used in all pharmacy settings that use electronic decision support to detect potential DDIs, including large and small community chain pharmacies, community independent pharmacies, hospital pharmacies, and governmental facility pharmacies.
Practice innovation: A tool is provided to determine the ability of pharmacy CDS systems to identify established DDIs. It can be adapted to evaluate potential DDIs that reflect local practice patterns and patient safety priorities. Beyond assessing software performance, going through the evaluation processes creates the opportunity to evaluate inadequacies in policies, procedures, workflow, and training of all pharmacy staff relating to pharmacy information systems and DDIs.
Conclusion: The DDI evaluation tool can be used to assess pharmacy information systems' ability to recognize relevant DDIs. Suggestions for improvement include determining whether the software allows for customization, creating standard policies for handling specific interactions, and ensuring that drug knowledge database updates occur frequently.
Similar articles
-
Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.Res Social Adm Pharm. 2011 Dec;7(4):359-68. doi: 10.1016/j.sapharm.2010.10.007. Epub 2011 May 6. Res Social Adm Pharm. 2011. PMID: 21530417
-
Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions.J Am Med Inform Assoc. 2011 Jan-Feb;18(1):32-7. doi: 10.1136/jamia.2010.007609. Epub 2010 Dec 3. J Am Med Inform Assoc. 2011. PMID: 21131607 Free PMC article.
-
Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.Med Care. 2007 May;45(5):456-62. doi: 10.1097/01.mlr.0000257839.83765.07. Med Care. 2007. PMID: 17446832
-
Review of computerized clinical decision support in community pharmacy.J Clin Pharm Ther. 2014 Aug;39(4):343-8. doi: 10.1111/jcpt.12168. Epub 2014 May 8. J Clin Pharm Ther. 2014. PMID: 24806361 Review.
-
Pharmaceutical care in community pharmacies: practice and research in Sweden.Ann Pharmacother. 2006 Jun;40(6):1162-9. doi: 10.1345/aph.1G680. Epub 2006 May 30. Ann Pharmacother. 2006. PMID: 16735653 Review.
Cited by
-
Potential Drug Interactions in Adults Living in Manaus: A Real-World Comparison of Two Databases, 2019.Turk J Pharm Sci. 2022 Oct 31;19(5):543-551. doi: 10.4274/tjps.galenos.2021.96603. Turk J Pharm Sci. 2022. PMID: 36317874 Free PMC article.
-
Determination of Potential Drug-Drug Interactions Using Various Software Programs in a Community Pharmacy Setting.Turk J Pharm Sci. 2019 Mar;16(1):14-19. doi: 10.4274/tjps.30932. Epub 2018 Dec 31. Turk J Pharm Sci. 2019. PMID: 32454689 Free PMC article.
-
Hospital Pharmacists' Perceptions and Decision-Making Related to Drug-Drug Interactions.Can J Hosp Pharm. 2019 Jul-Aug;72(4):288-294. Epub 2018 Aug 31. Can J Hosp Pharm. 2019. PMID: 31452540 Free PMC article.
-
Clinical Utility of Definitive Drug⁻Drug Interaction Testing in Primary Care.J Clin Med. 2018 Oct 25;7(11):384. doi: 10.3390/jcm7110384. J Clin Med. 2018. PMID: 30366371 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
